A method for isolating innate lymphocytes from mouse meninges and its application

The method of isolating intrinsic lymphocytes from mouse meninges, including dissection, digestion, staining, and flow cytometry, has solved the problem of the difficulty in isolating and analyzing intrinsic lymphocytes in existing technologies, revealed their changes in stroke, and provided an experimental basis for meningeal immunology research.

CN115418350BInactive Publication Date: 2024-11-12UNIV OF SCI & TECH OF CHINA +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211064482.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-09-01
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Current technology lacks effective methods for isolating and analyzing intrinsic lymphocytes in the mouse meninges, especially in meningeal immunology research, which hinders a deeper understanding of cardiovascular and cerebrovascular diseases and the development of treatments.

Method used

A method for isolating intrinsic lymphocytes from mouse meninges is provided, including meningeal dissection, tissue digestion, density gradient centrifugation, cell staining, and flow cytometry analysis. Detailed steps include anesthetizing mice, cardiac perfusion, tissue mincing, collagenase digestion, filtration, Percoll centrifugation, cell blocking, surface and nuclear staining, and finally, the cell content and subpopulations are detected by flow cytometry.

Benefits of technology

Stable isolation and detection of intrinsic lymphocytes in mouse meninges were achieved, revealing changes in intrinsic lymphocytes in stroke, providing an experimental basis for meningeal immunology research, and offering new perspectives and methods for the study of cardiovascular and cerebrovascular diseases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115418350B_ABST
    Figure CN115418350B_ABST
Patent Text Reader

Abstract

The present invention provides a method for isolating innate lymphocytes from mouse meninges, and demonstrates the important application of this method in the study of brain diseases. The process of this method includes: correctly peeling off the mouse meninges, chopping, digesting with collagenase and obtaining meningeal digestion solution, separating mononuclear cells in the meninges by percoll density gradient centrifugation, cell surface staining combined with nuclear staining and flow cytometry to detect the proportion of innate lymphocytes and innate lymphocyte subsets (ILC1, ILC2, ILC3) and other processes. The present invention effectively detects innate lymphocytes in mouse meninges, fills the gap that people have been unable to directly obtain brain innate lymphocytes for a long time, and lays an experimental foundation for the research work of meningeal immunity.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of cell separation, and relates to a method for separating innate lymphocytes from mouse meninges and application thereof. Background Art

[0002] The brain has long been considered an immune privileged system protected by the blood-brain barrier. Traditional theories have held that the brain does not participate in immune responses because it lacks lymphatic drainage and is difficult for immune cells to reach. Until recently, it was discovered that there are stable lymphatic vessels in the meninges. Further experiments have shown that the meninges play an important role in directing and coordinating immunity.

[0003] Nowadays, meningeal immunity has been widely used by domestic and foreign research institutions in the study of various cardiovascular and cerebrovascular diseases, and has demonstrated its great clinical value. However, people's understanding of meningeal immunity is still very lacking, many important mechanisms are still unclear, and experimental means and methods are relatively scarce. In particular, there are few reports on the study of innate lymphocytes in the meninges.

[0004] Intrinsic lymphocytes are a new type of immune cell that have received widespread attention in recent years. Intrinsic lymphocytes promote immunity by secreting cytokines and regulating immune cells. Intrinsic lymphocytes mainly reside in tissues, and most of them exist in lymphoid and non-lymphoid tissues. Studies have shown that detecting intrinsic lymphocytes in different tissues is of great value in determining disease mechanisms and developing new means to treat diseases. Current experiments have shown that intrinsic lymphocytes have potential applications in regulating cardiovascular and cerebrovascular diseases and marking disease states. With the continuous deepening of research on meningeal immunity, directly isolating intrinsic lymphocytes from the meninges is of great significance for the study of cardiovascular and cerebrovascular diseases. However, there is still a lack of practical methods for isolating intrinsic lymphocytes in mouse meninges.

[0005] The present invention provides a method for isolating innate lymphocytes in mouse meninges based on mouse meningeal stripping method and flow cytometric analysis technology, and applies this method to the study of stroke disease, analyzes the changes of innate lymphocytes in meninges during the disease and recovery process of mice, and thus innate lymphocytes can be used as a marker of the stroke process. This work lays an experimental foundation for more comprehensive meningeal innate immunity experiments in the future. Summary of the invention

[0006] The first purpose of the present invention is to fill the gap in the current technology for detecting innate lymphocytes in meningeal immunity research, and to provide a method for isolating innate lymphocytes from mouse meninges. This method can maturely and stably detect innate lymphocytes in mouse meninges, providing technical support for future meningeal immunology experiments. The present invention also includes two steps: stripping mouse meninges that can be used in subsequent detection steps and preparing samples that can be used in flow cytometry detection schemes.

[0007] The first object of the present invention can be achieved by the following technical solutions:

[0008] A method for isolating innate lymphocytes from mouse meninges, the method comprising the following steps:

[0009] Step 1: Open the sterile operating table and anesthetize the mouse;

[0010] Step 2: Perform cardiac perfusion on mice, peel off the meninges of mice, and collect the meningeal tissue of mice;

[0011] Step 3: mince and digest the obtained tissue;

[0012] Step 4: Filter the digestion solution and lightly grind the undigested part through the filter, centrifuge and remove the supernatant;

[0013] Step 5: Perform percoll density gradient centrifugation and collect the cells precipitated at the bottom;

[0014] Step 6: Add CD16 / 32 to the collected cells and block for 5 minutes in the dark;

[0015] Step 7: After blocking the sample from light, stain the cell surface and incubate it in the dark for 30 minutes;

[0016] Step 8: Add PBS buffer to the sample treated in step 7 and wash;

[0017] Step 9: Fix cell surface antibodies, break the cell nuclear membrane, wash, and perform intranuclear staining;

[0018] Step 10: Use flow cytometry to analyze the stained single cell suspension and detect the content of innate lymphocytes and the proportion of innate lymphocyte subsets (ILC1, ILC2, ILC3).

[0019] Furthermore, in the step 2, after the mouse is anesthetized, it is perfused transcardially with 0.01M ice-cold PBS with a pH value of 7.4 to remove peripheral blood;

[0020] Furthermore, according to a specific embodiment of the invention, the mouse is killed by spinal dislocation and then decapitated, and the mouse skull is surgically operated to peel off the mouse meninges, and the mouse meninges at different parts are collected respectively. The specific process of peeling off the mouse meninges is detailed in the specific embodiment.

[0021] Further, the collagenase and solution used in step 3 are 2.0 mg / mL collagenase D and 0.1 mg / mL DNase I in Hanks' balanced salt solution (HBSS);

[0022] Furthermore, the digestion conditions were set as follows: 35 minutes at 37°C with low rotation on a rocker.

[0023] Furthermore, in the step 4, the upper clear layer is taken and passed through a 100-mesh filter.

[0024] Furthermore, the Percoll formula in step 5 is: 3.7 ml Percoll stock solution (GE Healthcare) + 1 ml 10×PBS 5.3 ml pure water. (per 10 ml)

[0025] Furthermore, in step six, the CD16 / 32 blocking non-specific antibody can achieve a good blocking effect by adding 0.5ul to each sample.

[0026] Furthermore, in step seven, 0.5ul / test of live / dead dye was first added, and then cell surface antibody staining was performed with 1.5ul / test of PerCP.Cy5.5-anti mouse CD45, PE-Cy7-anti mouse CD127, PE-anti mouse-ST2, and 5ul / test of FITC-anti mouse Lineage Cocktail.

[0027] Furthermore, in step eight, 1 ml of PBS buffer was added to each tube to remove excess dye, and the centrifugation conditions were 4° C., 350 g×5 min.

[0028] Furthermore, in step nine, 1 ml / test of the fixation and permeabilization solution is added, and the cells are incubated in a 4° C. refrigerator away from light for 40-50 min;

[0029] Furthermore, after the above steps were completed, 1 ml of 1× washing solution 930 g was used for washing twice for 5 min.

[0030] Furthermore, in step ten, a BD canto II flow analyzer is used for flow cytometric analysis; the flow cytometer is set to CD45+Lineage-CD127+ to detect innate lymphocytes; the flow cytometer is set to CD45+Lineage-CD127+Tbet+ to detect ILC1 cells; the flow cytometer is set to CD45+Lineage-CD127+ST2+ to detect ILC2 cells; the flow cytometer is set to CD45+Lineage-CD127+RORγt+ cells to detect ILC3 cells.

[0031] The second object of the present invention is to utilize the above method to demonstrate important applications in brain disease research.

[0032] The second object of the present invention can be achieved by the following technical solutions:

[0033] An application for isolating innate lymphocytes from mouse meninges. The application can use the above method to detect the innate lymphocyte content in the meninges of sham-operated and middle cerebral artery occlusion (MCAO) mice, as well as the imbalance of innate lymphocyte subsets, so as to analyze the clinical application of meningeal immunity.

[0034] Furthermore, in this application, we took two groups of mice to detect innate lymphocytes and their subsets in the meninges, one group of mice was a sham operation group, and the other group of mice was operated to cause middle cerebral artery occlusion (MCAO) disease.

[0035] The test results showed that the number of innate lymphocytes in the meninges of MCAO mice increased, and there was an obvious imbalance of innate lymphocyte subpopulations. The content of ILC1 cells increased significantly, and the content of ILC3 cells increased slightly.

[0036] The results also indicate that imbalance of innate lymphocyte subsets can serve as a marker for cardiovascular and cerebrovascular diseases. In the occurrence of new cerebrovascular diseases, innate lymphocytes play an immune role. The specific mechanism may become the key to deciphering the meningeal immune mechanism.

[0037] Compared with the prior art, the method and application of isolating innate lymphocytes from mouse meninges has the following advantages:

[0038] The present invention provides a complete method for detecting innate lymphocytes in mouse meninges, from stripping of meninges, staining to flow cytometry detection, filling the long-standing gap in the study of cardiovascular and cerebrovascular diseases, which has not been able to directly analyze innate lymphocytes in meninges experimentally.

[0039] Compared with previous research methods on cardiovascular and cerebrovascular diseases, experiments on meningeal immunity will explore the causes, mechanisms and treatments of these diseases from a more fundamental, broader and more novel perspective, and have very broad application prospects and clinical value.

[0040] The present invention lays an experimental foundation for future research on meningeal immunity and provides new ideas and methods for the research field of innate lymphocytes. BRIEF DESCRIPTION OF THE DRAWINGS

[0041] Figure 1 Schematic diagram of the process for isolating innate lymphocytes from mouse meninges;

[0042] Figure 2 Schematic diagram of flow cytometry analysis of innate lymphocytes;

[0043] Figure 3 Schematic diagram for further flow cytometry analysis of innate lymphocyte subsets (ILC1, ILC2, ILC3);

[0044] Figure 4 This is a graph showing the results of comparing the content of innate lymphocytes and their subsets in the meninges of MCAO-affected mice with that of the sham-operated group. DETAILED DESCRIPTION

[0045] In order to understand the present invention more clearly, the present invention is further described with reference to the following examples and drawings. The examples are only used for explanation and are not intended to limit the present invention in any way. The experimental methods without specifying specific conditions in the examples are conventional methods and conventional conditions well known in the art, or according to the conditions recommended by the manufacturer.

[0046] like Figure 1-Figure 4 As shown, this embodiment provides a method for isolating innate lymphocytes from mouse meninges, the method comprising the following steps:

[0047] (1) Open the sterile operating platform and perform the following entire operation process in a sterile environment.

[0048] (2) After the mouse was thoroughly anesthetized, pH 7.4, 0.01 M PBS was thoroughly perfused transcardially, and mice were killed by spinal dislocation; decapitation was performed, the scalp was cut to expose the complete skull, and then the skull of the mouse was fixed at the eye socket with hook forceps, and microscissors were inserted from the head into the foramina magnum on both sides, and then cut along the bone toward the ipsilateral eye socket, and then cut from the middle of the mouse eye socket; the skull was cut along the scalp from the midline of the skull to the midline of the eye socket, and then the left and right skulls were opened to both sides from the midline of the skull with curved micro-bent forceps to expose the entire brain, and the nerves on the ventral side of the brain were carefully cut with micro-scissors, and then the entire brain was carefully opened to collect the entire skull of the mouse; the brain and the removed skull were placed in DMEM culture medium containing 5% serum on ice, and the meninges were peeled off from the surface of the brain and the inside of the skull from the outside to the inside; next, the brain was divided into cerebellum, brainstem and cerebrum, and the meninges were collected from the ventricles, brainstem and cerebellar folds respectively.

[0049] (3) The meningeal tissue of the animal group was completely peeled off and minced with a blade. The tissue block was placed in a centrifuge tube and 3 ml of calcium and magnesium ions were added. Then it was placed in Hanks balanced salt solution (HBSS) containing 2.mg / mL collagenase D and 0.1mg / mL DNase I, and rotated at low speed on a rocker at 37°C for 30-35 minutes. The supernatant was then passed through a 100-mesh filter, and the undigested tissue was slightly ground and passed through the filter; washed once with 1×PBS buffer and centrifuged (350g for 5min), the supernatant was discarded, the cells were resuspended in 37% Percoll and centrifuged at 930g for 20 minutes at 25°C, 3 up and 1 down; the formula of 10ml 37% Percoll is: 3.7ml Percoll stock solution (GE Healthcare) + 1ml 10×PBS 5.3ml pure water; the supernatant was carefully aspirated with a Pasteur tube, and 10ml Wash once with 1×PBS, centrifuge at 350g for 5 min, leave about 100ul of the precipitated cells and transfer to a new 2ml EP tube.

[0050] (4) Add 0.5ul / test CD16 / 32 to the EP tube used to collect the single-cell suspension and incubate at 4°C in the dark for 5 minutes.

[0051] (5) Then, the staining process was carried out. First, 0.5ul / test of live / dead dye was added and mixed, and the mixture was incubated at 4°C in the dark for 15min. Then, cell surface antibody staining was performed with 1.5ul / test of PerCP.Cy5.5-anti mouse CD45, PE-Cy7-anti mouse CD127, PE-anti mouse-ST2, and 5ul / test of FITC-anti mouse Lineage Cocktail (all antibodies were from BD Company), and the mixture was incubated at 4°C in the dark for 30min.

[0052] (6) After completing step (5), add 1ml PBS to the sample, wash once at 4℃350g×5min; continue to add 1ml / test fixation and membrane permeabilization solution and fix and permeabilize for 40-50min at 4℃ in the dark, then wash twice with 1ml 1× wash solution 930g 5min wash solution; after fixing the surface antibody dye and permeating the nuclear membrane, stain the nuclear transcription factors with 1.5ul / test APC-anti mouse RORγt, BV421-anti mouse Tbet, incubate at 4℃ in the dark for 30min, then wash twice with 1ml 1× wash solution 930g 5min wash solution, filter and put it on the machine.

[0053] (7) After completing step (6), the processed sample is analyzed using a flow cytometer, such as Figure 2 As shown, the gating strategy of the flow cytometer is: CD45+Lineage-CD127+, to detect innate lymphocytes; then detect innate lymphocyte subsets (ILC1, ILC2, ILC3), set the flow cytometer to CD45+Lineage-CD127+Tbet+, detect ILC1 cells; set the flow cytometer to CD45+Lineage-CD127+ST2+, detect ILC2 cells; set the flow cytometer to CD45+Lineage-CD127+RORγt+ cells, detect ILC3 cells; adjust the voltage, after compensation, collect sample data to complete the detection of innate lymphocytes and their subsets in mouse meninges.

[0054] The specific embodiments described herein are merely examples of the spirit of the present invention. Those skilled in the art may make various modifications or additions to the specific embodiments described or replace them in similar ways, but they will not deviate from the spirit of the present invention or exceed the scope defined by the appended claims.

Claims

1. A method for isolating innate lymphocytes from mouse meninges, characterized in that: The method comprises the following steps: Correctly peel off the mouse meninges and collect the mouse meningeal tissue; The obtained tissue is minced, digested, filtered, centrifuged, and the precipitate is taken; Mononuclear cells in the meninges were isolated by percoll density gradient centrifugation; The non-specific antibodies on the surface of collected monocytes were blocked; The blocked samples were stained for dead or alive and cell surface staining and incubated in the dark; Add buffer and wash; After fixation and breaking of the nuclear membrane, the cells were washed and then stained for transcription factors in the nucleus; Analyze the stained cell suspension samples using a flow cytometer, and detect the content of innate lymphocytes in the samples and the proportion of innate lymphocyte subsets ILC1, ILC2, and ILC3; The steps of collecting meninges are as follows: First, mice were thoroughly perfused transcardially with 0.01 M PBS, pH 7.4, and then killed by spinal cord dislocation; The scalp was cut off by decapitation to expose the complete skull, and the whole skull of the mouse was collected after surgical treatment; The meninges were peeled off from the brain surface and the inside of the skull in a lateral to medial direction; The brain was divided into cerebellum, brainstem, and cerebrum, and the meninges were collected from the ventricles, brainstem, and cerebellar folds, respectively; The steps of the digestion operation are as follows: Add 3-5 ml of 2-2.5 mg / ml collagenase D and 0.1 mg / ml DNase1 to the meninges of each mouse for digestion. After adding collagenase D, slowly rotate on a rocker in a 37°C incubator for digestion for 30-35 minutes. The digestion solution of the meningeal tissue is filtered through a 100-mesh sieve; The Percoll method for isolating meningeal lymphocytes is as follows: resuspend the precipitate with 5 ml of 35%-40% Percoll and centrifuge at 930 g for 20 minutes; The operation of performing dead and live staining and cell surface staining on the sample after light protection and sealing is as follows: first add 0.5ul / test dead and live dye, then add 1.5ul / test PerCP .Cy5 .5- anti mouse CD45, PE-Cy7-anti mouseCD127, PE -anti mouse-ST2, 5ul / test FITC-anti mouse Lineage Cocktail for cell surface antibody staining; The operation of analyzing the stained samples using a flow analyzer is as follows: setting the flow cytometer to CD45+Lineage-CD127+ to detect innate lymphocytes; setting the flow cytometer to CD45+Lineage-CD127+Tbet+ to detect ILC1 cells; setting the flow cytometer to CD45+Lineage-CD127+ST2+ to detect ILC2 cells; setting the flow cytometer to CD45+Lineage-CD127+RORγt+ cells to detect ILC3 cells.